IMR Press / FBL / Volume 12 / Issue 3 / DOI: 10.2741/2132

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Mitochondrial dysfunction in human pathologies
Show Less
1 Centro de Investigaciones Biológicas (Consejo Superior de Investigaciones Científicas). Ramiro de Maeztu 9, 28040, Madrid, Spain
2 Centro Nacional de Investigaciones Cardiovasculares (Instituto de Salud Carlos III), Melchor Fernandez Almagro 3, 28029, Madrid, Spain
3 Instituto “Reina Sofía” de Investigaciones Nefrológicas, Spain
Front. Biosci. (Landmark Ed) 2007, 12(3), 1131–1153; https://doi.org/10.2741/2132
Published: 1 January 2007
Abstract

The integrity of mitochondrial function is fundamental to cell life. The cell demands for mitochondria and their complex integration into cell biology, extends far beyond the provision of ATP. It follows that disturbances of mitochondrial function lead to disruption of cell function, expressed as disease or even death. Mitochondria are major producers of free radical species and also possibly of nitric oxide, and are, at the same time, major targets for oxidative damage. In this review we consider recent developments in our knowledge of how the mitochondrial production of reactive oxygen species (ROS) plays a critical role in several major human pathologies. We will also consider recent advances in our understanding of the molecular mechanisms involved in mitochondrial ROS detoxification.

Share
Back to top